The independent platform for news, articles and advice for professionals in laboratory medicine

Isohelix to seek FDA approval for GeneFix Collectors

Isohelix, a UK-based specialist biological sample collection company, has begun the process to gain full regulatory approval of the GeneFix Saliva DNA Collectors from the US Food and Drug Administration (FDA).

The GeneFix Saliva DNA/RNA Collection devices are designed for the collection and preservation of DNA/RNA from saliva, providing patients with the opportunity to provide high-quality samples for molecular diagnostics at both point of care settings and for over the counter direct to consumer genetic testing (OTC).

Isohelix has submitted via the FDA’s Pre-Submission process, which allows the company to clarify its testing and validation approach, confirm the appropriate regulatory application pathway (510k) and gain additional procedural feedback from the FDA with the aim of making the final submission process more efficient.

Since 2013, Isohelix has been successfully supplying its range of high-quality DNA and RNA saliva collectors and isolation products to the diagnostics, clinical and research markets, with many products already certified for use as IVDs across the globe. Isohelix is an international business marketing its sizeable product range through customers in many countries worldwide.

Tom Hole, CEO of Isohelix, said: "The US is a particularly attractive territory and the 510 (K) would allow us to supply our products into the rapidly expanding areas of Molecular and Precision Genetic Diagnosis and Testing, where saliva has become a strong choice as an alternative to blood or the use of buccal swabs. Isohelix provides saliva collectors that are proven to cope with the most demanding downstream processes, yet are easy to use for automated applications, non-hazardous and reliably stabilise both DNA and RNA over extended periods at room temperature.

For further details please visit www.isohelix.com.

 

Upcoming Events

POCT: The Power to Disrupt

The Jubilee Hotel and Conferences, Nottingham
28 March 2023

Microbiology Society Annual Conference 2023

Birmingham International Convention Centre.
17-20 April 2023

British Society for Microbial Technology Annual Microbiology Conference

Royal Air Force Museum, Hendon, London
11 May 2023

Microscience Microscopy Congress 2023 (mmc 2023, incorporating EMAG 2023)

Manchester Central Conference Centre
4-6 July 2023

Annual SHOT Symposium 2023

Etihad Stadium, Manchester, M11 3FF
4 July 2023

IBMS Congress 2023

ICC Birmingham
25-28 September 2023

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

POCT: The Power to Disrupt

The Jubilee Hotel and Conferences, Nottingham
28 March 2023

Microbiology Society Annual Conference 2023

Birmingham International Convention Centre.
17-20 April 2023

British Society for Microbial Technology Annual Microbiology Conference

Royal Air Force Museum, Hendon, London
11 May 2023

Microscience Microscopy Congress 2023 (mmc 2023, incorporating EMAG 2023)

Manchester Central Conference Centre
4-6 July 2023

Annual SHOT Symposium 2023

Etihad Stadium, Manchester, M11 3FF
4 July 2023

IBMS Congress 2023

ICC Birmingham
25-28 September 2023

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2023 Step Communications Ltd. Registered in England. Registration Number 3893025